Download PDF

Other users also viewed these articles

Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy Joan Martínez-Campreciós; Mar Riveiro-Barciela; Raquel Muñoz-Gómez; María-Carlota Londoño; Mercé Roget; Miguel Ángel Serra; Desamparados Escudero-García; Laura Purchades; Manuel Rodríguez; Juan E. Losa-García; María L. Gutiérrez; Isabel Carmona; Javier García-Samaniego; Luís Morano; Ignacio Martín-Granizo; Marta Montero-Alonso; Martín Prieto; Manuel Delgado; Natalia Ramos; María A. Azancot; Francisco Rodríguez-Frías; Maria Buti;
Gastroenterol Hepatol. 2023;46:594-602
Evolution of patients with chronic hepatitis C infection with advanced fibrosis or cirrhosis cured with direct-acting antivirals. Long-term follow-up Ester Badia Aranda; Cristina Fernández Marcos; Aida Puebla Maestu; Visitación Gozalo Marín; Raquel Vinuesa Campo; Sara Calvo Simal; Judith Gómez Camarero;
Gastroenterol Hepatol. 2022;45:767-79
Externalized nurse-led model for hepatitis C virus microelimination and impact of drug use profile Anna Miralpeix; Paula Ibáñez; Víctor Navarro; Patricia Colomera; Montserrat Gálvez; Zoe Mariño; Xavier Major; Joan Colom; Xavier Forns; Sabela Lens;
Gastroenterol Hepatol. 2025;48: